440 filings
Page 7 of 22
8-K
e9yotf2qfw1 g8tx4w
9 Mar 21
Departure of Directors or Certain Officers
5:16pm
8-K
ropqjkwj18qy 8a
16 Feb 21
Other Events
11:07am
8-K
7ekh14xjl
21 Jan 21
Entry into a Material Definitive Agreement
5:29pm
424B5
37dwlvgh9jse4 pdlnf4
21 Jan 21
Prospectus supplement for primary offering
5:29pm
424B5
zlqraz4zs2etu54 g25s
19 Jan 21
Prospectus supplement for primary offering
4:31pm
8-K
tyi51053b2
14 Jan 21
AcelRx Announces Year-End 2020 Metrics and Review of 2020 Achievements
8:53am
424B5
gyzrsg snlpq9hmzae2n
10 Dec 20
Prospectus supplement for primary offering
4:17pm
8-K
ei08 0i8pna
10 Dec 20
Securities Purchase Agreement
4:16pm
8-K
mnwbatcbqw13nwf3f5j
5 Nov 20
AcelRx Pharmaceuticals Reports Third Quarter 2020 Financial Results
4:16pm
8-K
79x1j45l 8mb
6 Oct 20
Entry into a Material Definitive Agreement
4:07pm
8-K
a4rxoqhdncwz7
10 Aug 20
AcelRx Pharmaceuticals Reports Second Quarter 2020 Financial Results
4:01pm
424B5
hrqux2w
23 Jul 20
Prospectus supplement for primary offering
4:39pm
8-K
mvlngh8bxe5viuun
23 Jul 20
AcelRx expands DSUVIA commercial opportunity with an established, leading partner to advance surgical care
8:50am
EFFECT
3ip75n33k4t7
9 Jul 20
Notice of effectiveness
12:15am
CORRESP
f1f1qqs3ev5b2
7 Jul 20
Correspondence with SEC
12:00am
CORRESP
eexfng3lpxl0m885cc3
6 Jul 20
Correspondence with SEC
12:00am
CORRESP
5wvx 6n3y
6 Jul 20
Correspondence with SEC
12:00am
EFFECT
og3ft
18 Jun 20
Notice of effectiveness
12:15am